Related stories
Merck Reports Q3 Winrevair Sales of $694 Million
M impact | EARNINGS | Oct 29, 2026, 10:46 AM UTC
Merck Q3 Gardasil Sales $1.995 Billion
M impact | EARNINGS | Oct 29, 2026, 10:45 AM UTC
D.R. Horton Reports Fiscal 2026 Results, Raises Quarterly Dividend to $0.50
D.R. Horton reported fourth-quarter and fiscal 2026 earnings and increased its quarterly dividend to $0.50 per share.
M impact | EARNINGS | Oct 29, 2026, 10:31 AM UTC
Merck forecasts FY adjusted EPS of $2.77-$2.82
Merck's FY adjusted EPS outlook is $2.77-$2.82, versus the IBES estimate of $2.65.
M impact | EARNINGS | Oct 29, 2026, 10:31 AM UTC
Merck forecasts FY sales of $66.8 billion to $67.3 billion
Merck's full-year worldwide sales outlook is $66.8 billion to $67.3 billion, versus an IBES estimate of $67.03 billion.
M impact | EARNINGS | Oct 29, 2026, 10:31 AM UTC
IDACORP Reports Q3 EPS of USD 2.73
L impact | EARNINGS | Oct 29, 2026, 10:31 AM UTC